Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.

Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melén K, Julkunen I, Taskinen J.

Biochemistry. 1995 Apr 4;34(13):4202-10.

PMID:
7703232
2.

Purification methods of mammalian catechol-O-methyltransferases.

Tilgmann C, Ulmanen I.

J Chromatogr B Biomed Appl. 1996 Sep 20;684(1-2):147-61. Review.

PMID:
8906471
4.

Separation methods for catechol O-methyltransferase activity assay: physiological and pathophysiological relevance.

Pihlavisto P, Reenilä I.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Dec 5;781(1-2):359-72. Review.

PMID:
12450669
5.

Distribution and functions of catechol-O-methyltransferase proteins: do recent findings change the picture?

Myöhänen TT, Männistö PT.

Int Rev Neurobiol. 2010;95:29-47. doi: 10.1016/B978-0-12-381326-8.00003-X. Review.

PMID:
21095458
6.

Catechol-O-methyltransferase enzyme: cofactor S-adenosyl-L-methionine and related mechanisms.

Müller T.

Int Rev Neurobiol. 2010;95:49-71. doi: 10.1016/B978-0-12-381326-8.00004-1. Review.

PMID:
21095459
7.

The interaction of transport mechanisms and intracellular enzymes in metabolizing systems.

Trendelenburg U.

J Neural Transm Suppl. 1990;32:3-18. Review.

PMID:
2089098
8.

Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors.

Männistö PT, Ulmanen I, Lundström K, Taskinen J, Tenhunen J, Tilgmann C, Kaakkola S.

Prog Drug Res. 1992;39:291-350. Review. No abstract available.

PMID:
1475365
9.

[Association of genetic polymorphisms of COMT gene with psychiatric disorders].

Gao LB, Zhong SR, Jing Q.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Dec;27(6):650-3. doi: 10.3760/cma.j.issn.1003-9406.2010.06.010. Review. Chinese.

PMID:
21154325
10.

Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters.

Roth JA.

Rev Physiol Biochem Pharmacol. 1992;120:1-29. Review. No abstract available.

PMID:
1519017
11.

Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders.

Ma Z, Liu H, Wu B.

Br J Clin Pharmacol. 2014 Mar;77(3):410-20. doi: 10.1111/bcp.12169. Review.

12.

The structural biology of oestrogen metabolism.

Thomas MP, Potter BV.

J Steroid Biochem Mol Biol. 2013 Sep;137:27-49. doi: 10.1016/j.jsbmb.2012.12.014. Epub 2013 Jan 4. Review.

13.

Ascorbic acid and catecholamines.

[No authors listed]

Nutr Rev. 1976 Jun;34(6):181-2. Review. No abstract available.

PMID:
781556
14.

Cloning, expression and structure of catechol-O-methyltransferase.

Lundström K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Ulmanen I.

Biochim Biophys Acta. 1995 Aug 16;1251(1):1-10. Review. No abstract available.

PMID:
7647086
15.

Inhibitors of catechol-O-methyltransferase in the treatment of neurological disorders.

Jatana N, Apoorva N, Malik S, Sharma A, Latha N.

Cent Nerv Syst Agents Med Chem. 2013;13(3):166-94. Review.

PMID:
24450388
16.

Extraneuronal uptake and metabolism of catecholamines as a site of loss.

Trendelenburg U.

Life Sci. 1978 Apr 3-17;22(13-15):1217-22. Review. No abstract available.

PMID:
351318
17.

Single isotope derivative (radioenzymatic) methods in the measurement of catecholamines.

Johnson GA, Kupiecki RM, Baker CA.

Metabolism. 1980 Nov;29(11 Suppl 1):1106-13. Review. No abstract available.

PMID:
7001177
Items per page

Supplemental Content

Write to the Help Desk